Form D — OS Therapies Inc
0001795091-26-000001 · filed Jan 20, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $7,531,884
- Reported amount sold
- $3,498,650
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OS Therapies Inc
- CIK
- 1795091
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 115 Pullman Crossing Road
Grasonville, Maryland 21638 - Phone
- 410-297-7793
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul A. Romness · Executive OfficerGrasonville, Maryland Find on LinkedIn ↗
-
Robert G. Petit · Executive OfficerGrasonville, Maryland Find on LinkedIn ↗
-
Christopher P. Acevedo · Executive OfficerGrasonville, Maryland Find on LinkedIn ↗
-
John Ciccio · DirectorGrasonville, Maryland Find on LinkedIn ↗
-
Avril McKean Dieser · DirectorGrasonville, Maryland Find on LinkedIn ↗
-
Karim Galzahr · DirectorGrasonville, Maryland Find on LinkedIn ↗
-
Olivier Jarry · DirectorGrasonville, Maryland Find on LinkedIn ↗
-
Theodore F. Search · DirectorGrasonville, Maryland Find on LinkedIn ↗
Other filings from this issuer
- Form D — Oct 23, 2026 — 0000921895-26-002846
- Form D — Aug 25, 2026 — 0000921895-26-002306
- Form D — Jul 16, 2026 — 0001795091-26-000003
- Form D — Mar 6, 2026 — 0001795091-26-000002
- Form D — Sep 10, 2025 — 0000921895-25-002566
- Form D — Jul 16, 2025 — 0000921895-25-002001
- Form D — Jan 22, 2025 — 0001795091-25-000004
View the original filing on SEC EDGAR ↗